Four 20 Pharma

Dortmund, GermanyFounded 2017

About Four 20 Pharma

Four 20 Pharma is a German pharmaceutical company specializing in the production and distribution of EU-GMP-certified medical cannabis. Operating from Dortmund, the company sources cannabis from qualified international producers and manufactures finished pharmaceutical products for the German market. Four 20 Pharma holds a narcotics manufacturing license and is one of the leading pharmaceutical cannabis companies in Germany.

Key Facts

  • 1Holds a German narcotics manufacturing and distribution license
  • 2All products are EU-GMP certified and pharmacy-ready
  • 3Sources from qualified producers in Canada, Portugal, and Africa
  • 4Became part of Curaleaf International through acquisition

Frequently Asked Questions

What does EU-GMP certification mean for Four 20 Pharma?

EU-GMP (Good Manufacturing Practice) certification means Four 20 Pharma's production processes meet the European standard for pharmaceutical manufacturing, ensuring consistent quality, safety, and traceability of all cannabis products.

Is Four 20 Pharma part of a larger company?

Four 20 Pharma was acquired by Curaleaf International (formerly EMMAC Life Sciences), making it part of one of the world's largest cannabis companies with a strong European footprint.

More Cannabis Companies in Dortmund

Cannabis Laws

Products

  • EU-GMP medical cannabis flowers
  • Cannabis extracts
  • Pharmaceutical cannabis preparations

Specialties

EU-GMP-certified cannabis manufacturingPharmaceutical narcotics license holderQuality-controlled cannabis sourcingGerman medical cannabis market supply

Company Details

Founded
2017
Publicly Traded
No
Browse all Producers & Growers
View more companies in this category

Related Companies

More in Germany

View all companies in Germany